61 related articles for article (PubMed ID: 17538098)
1. Macrocytosis and cobalamin deficiency in patients treated with sunitinib.
Gillessen S; Graf L; Korte W; Cerny T
N Engl J Med; 2007 May; 356(22):2330-1. PubMed ID: 17538098
[No Abstract] [Full Text] [Related]
2. Macrocytosis due to treatment with sunitinib.
Billemont B; Izzedine H; Rixe O
N Engl J Med; 2007 Sep; 357(13):1351-2; author reply 1352. PubMed ID: 17898111
[No Abstract] [Full Text] [Related]
3. Lung toxicity in a patient treated with sunitinib.
Boyle HJ; Chatté G; Rivoire M; Fléchon A
Eur Respir J; 2012 Nov; 40(5):1300-3. PubMed ID: 23115316
[No Abstract] [Full Text] [Related]
4. Cardiac toxicity of sunitinib.
Joensuu H
Lancet; 2007 Dec; 370(9604):1978-80. PubMed ID: 18083385
[No Abstract] [Full Text] [Related]
5. Cardiotoxicity associated with sunitinib.
Hariharan S; Lowry S
Lancet; 2008 Apr; 371(9620):1244-5; author reply 1245. PubMed ID: 18406854
[No Abstract] [Full Text] [Related]
6. Re: Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib.
Feldman DR; Martorella AJ; Robbins RJ; Motzer RJ
J Natl Cancer Inst; 2007 Jun; 99(12):974-5; author reply 976-7. PubMed ID: 17565156
[No Abstract] [Full Text] [Related]
7. Case of sunitinib-induced Stevens-Johnson syndrome.
Lee JH; Lee JH; Lee JH; Kim SY; Kim GM
J Dermatol; 2013 Sep; 40(9):753-4. PubMed ID: 23855706
[No Abstract] [Full Text] [Related]
8. Scrotal cutaneous side effects of sunitinib.
Billemont B; Barete S; Rixe O
N Engl J Med; 2008 Aug; 359(9):975-6; discussion 976. PubMed ID: 18753659
[No Abstract] [Full Text] [Related]
9. Pyoderma gangrenosum: another cutaneous side-effect of sunitinib?
ten Freyhaus K; Homey B; Bieber T; Wilsmann-Theis D
Br J Dermatol; 2008 Jul; 159(1):242-3. PubMed ID: 18489600
[No Abstract] [Full Text] [Related]
10. Re: Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib.
Garfield DH; Hercbergs A; Davis PJ
J Natl Cancer Inst; 2007 Jun; 99(12):975-6; author reply 976-7. PubMed ID: 17565154
[No Abstract] [Full Text] [Related]
11. Sunitinib-associated thrombotic microangiopathy: a significant risk.
Buckley FD; Preston G; Meiklejohn DJ; Adamson D
Clin Oncol (R Coll Radiol); 2014 Aug; 26(8):515. PubMed ID: 24746506
[No Abstract] [Full Text] [Related]
12. Eccrine squamous syringometaplasia associated with sunitinib therapy.
Sheen YS; Huang CL; Chu CY
J Eur Acad Dermatol Venereol; 2007 Sep; 21(8):1136-7. PubMed ID: 17714156
[No Abstract] [Full Text] [Related]
13. Sunitinib-induced scrotal cutaneous side-effect.
Chou CY; Wang KH; Lin YH; Lin YT; Tsai HH
J Dermatol; 2013 Jan; 40(1):67-8. PubMed ID: 23078345
[No Abstract] [Full Text] [Related]
14. [Gottron-like papules induced by sunitinib].
Martorell-Calatayud A; Sanmartín O; Traves-Zapata V; Guillén C
Actas Dermosifiliogr; 2011 Jun; 102(5):385-7. PubMed ID: 21481331
[No Abstract] [Full Text] [Related]
15. Unanswered questions regarding the management of sunitinib-induced hypothyroidism.
Garfield D; Hercbergs A; Davis P
Nat Clin Pract Oncol; 2007 Dec; 4(12):674. PubMed ID: 17955044
[No Abstract] [Full Text] [Related]
16. Acute cardiac failure after sunitinib.
Machiels JP; Bletard N; Pirenne P; Jacquet L; Bonbled F; Duck L
Ann Oncol; 2008 Mar; 19(3):597-9. PubMed ID: 18272908
[No Abstract] [Full Text] [Related]
17. Images in clinical medicine. Sunitinib-associated hair depigmentation.
Brzezniak C; Szabo E
N Engl J Med; 2014 Apr; 370(17):e27. PubMed ID: 24758639
[No Abstract] [Full Text] [Related]
18. [New drugs; sunitinib and sorafenib].
Bellersen L
Ned Tijdschr Geneeskd; 2008 Feb; 152(8):469-70; author reply 470. PubMed ID: 18363211
[No Abstract] [Full Text] [Related]
19. Risks associated with sunitinib use and monitoring to improve patient outcomes.
Choi BS
Korean J Intern Med; 2014 Jan; 29(1):23-6. PubMed ID: 24574829
[No Abstract] [Full Text] [Related]
20. Erosive nappy erythema following sunitinib intake.
Kharmoum S; Errihani H
Pan Afr Med J; 2013; 14():46. PubMed ID: 23560129
[No Abstract] [Full Text] [Related]
[Next] [New Search]
